The advertisement promotes NUBEQA® (darolutamide), highlighting its relevance for patients experiencing rising PSA levels while on ADT (androgen deprivation therapy).
Creative Information
| CID: | 1e63a56c-0d24-4805-a5c7-89e41c884ef2 |
| CRID: | 82_1075-793619 |
| Domain: | nubeqa-us.com |
| Seat: | PP |
| Size: | 300x250 |
| Bid: | $2.93 |
| Timestamp: | 11/4/2025, 4:06:13 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/4/2025, 4:48:07 PM | 8.38s | |
| adomain_analysis | success | 11/4/2025, 6:47:13 PM | 3.32s | |
| adomain_capture | success | 11/4/2025, 6:47:09 PM | 0.10s | |
| ad_render | success | 11/4/2025, 4:47:59 PM | 25.57s | |
| brand_mapping | success | 11/4/2025, 4:06:13 PM | 0.09s | |
Analysis Results
Ad Format: banner
Brands: Nubeqa
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1346.91 KB | ||||||||||||||||||||||
| Render Time: | 9.90 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1346.96 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


